نتایج جستجو برای: 2 500

تعداد نتایج: 2580084  

Journal: :Revista Brasileira de Ciência Política 2013

Journal: :Balcanica Posnaniensia 2022

Artykuł poświęcony jest Flawiuszowi Patrycjuszowi, konsulowi roku 500. Przez kilkanaście lat był on bliskim współpracownikiem cesarza Anastazjusza, który powierzał mu odpowiedzialne zadania zarówno w sferze wojskowej, cywilnej, jak i religijnej, co świadczyło o tym, że ufał go doceniał. W czasie wy[1]borów władcy lipcu 518 r. to prawdopodobnie został okrzyknięty cesarzem przez gwardzistów podle...

Journal: :Orthopädie & Rheuma 2017

Journal: :Expert Syst. Appl. 2010
Pao-Hua Chou Pi-Hsiang Li Kuang-Ku Chen Menq-Jiun Wu

Department of Mechatronics Engineering, National Changhua University of Education, No. 2, Shi-da Road, Changhua City 500, Taiwan, ROC Department of Industrial Education and Technology, National Changhua University of Education, No. 2, Shi-da Road, Changhua City 500, Taiwan, ROC College of Business Administration, National Changhua University of Education, No. 2, Shi-da Road, Changhua City 500, ...

Journal: :Journal of the Chinese Medical Association : JCMA 2007
Hsin-Hsi Chien Chwen-Tzuei Chang Nain-Feng Chu Sheng-Hwu Hsieh Yu-Yao Huang I-Te Lee Wen-Jane Lee Yih-Jing Tang Wayne H H Sheu

BACKGROUND To evaluate the efficacy and safety of glyburide/metformin combined tablet compared to glyburide or metformin alone in patients with type 2 diabetes. METHODS In this 16-week, multicenter, randomized, double-blind, 4-arm and parallel clinical trial study, 100 patients with type 2 diabetes mellitus were recruited and 76 patients were available for statistical analysis at the end of t...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2007
John C Byrd Susan O'Brien Ian W Flinn Thomas J Kipps Mark Weiss Kanti Rai Thomas S Lin James Woodworth Dee Wynne Jennifer Reid Arturo Molina Bryan Leigh Sarah Harris

PURPOSE Therapeutic antibodies have improved the outcome for patients with chronic lymphocytic leukemia (CLL). We conducted a phase 1, dose escalation and schedule optimization study of the primatized anti-CD23 antibody, lumiliximab, in patients with previously treated and refractory CLL. EXPERIMENTAL DESIGN Forty-six patients were assigned sequentially to cohorts 1 through 6 and received lum...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید